Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass

Nature Genetics

Volumn 26, Issue 1, 2000, Pages 97-102

  Chen, Airu S ^a   Marsh, Donald J ^a   Trumbauer, Myrna E ^a   Frazier, Easter G ^a   Guan, Xiao Ming ^a   Yu, Hong ^a   Rosenblum, Charles I ^a   Vongs, Aurawan ^a   Feng, Yue ^a   Cao, Linhai ^a   Metzger, Joseph M ^a   Strack, Alison M ^a   Camacho, Ramon E ^a   Mellin, Theodore N ^a   Nunes, Christian N ^a   Min, William ^a   Fisher, Jill ^a   Gopal Truter, Shobhna ^a   MacIntyre, D Euan ^a   Chen, Howard Y ^a   Van Der Ploeg, Lex H T ^a   more..

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN RECEPTOR; THYROXINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GENE EXPRESSION; GENOTYPE; HOMEOSTASIS; HYPERINSULINEMIA; LEAN BODY WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; WEIGHT GAIN;

ADIPOSE TISSUE; AGE FACTORS; ALPHA-MSH; ANIMALS; BLOTTING, SOUTHERN; BODY TEMPERATURE; BODY WEIGHT; CALORIMETRY; CORTICOSTERONE; FEEDING BEHAVIOR; FEMALE; GENOTYPE; GLUCOSE; HUMANS; HYPERINSULINISM; IN SITU HYBRIDIZATION; INSULIN; LEPTIN; MALE; MICE; MICE, KNOCKOUT; MODELS, GENETIC; MOTOR ACTIVITY; OBESITY; OLIGOPEPTIDES; PHENOTYPE; PROTEIN ISOFORMS; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, CORTICOTROPIN; RECEPTORS, PEPTIDE; RECOMBINATION, GENETIC; THYROXINE; TIME FACTORS; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0033818103     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/79254     Document Type: Article

References (30)

1. Krude, H. et al. Severe early onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nature Genet. 19, 155-157 (1998).
2. Chagnon, Y.C. et al. Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the quebec family study. Mol. Med. 3, 663-673 (1997).
3. Yeo, G.S.H. et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nature Genet. 20, 111-112 (1998).
4. Vaisse, C., Clement, K., Guy-Grand, B. & Froguel, P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nature Genet. 20, 113-114 (1998).
5. y) mutation. Proc. Natl Acad. Sci. USA 91, 2562-2566 (1994).
6. Ollmann, M.M. et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278, 135-138 (1997).
7. Graham, M., Shutter, J.R., Sarmiento, U., Sarosi, I. & Stark, K.L. Overexpression of Agrt leads to obesity in transgenic mice. Nature Genet. 17, 273-274 (1997).
8. Huszar, D. et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131-141 (1997).
9. Fan, W., Boston, B.A., Kesterson, R.A., Hruby, V.J. & Cone, R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165-168 (1997).
10. Lu, D. et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371, 799-802 (1994).
11. Marsh, D.J. et al. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nature Genet. 21, 119-122 (1999).
12. Chen, A.S. et al. Role of the melanocortin-4 receptor in metabolic rate and food intake in mice. Transgenic Res. (in press).
13. Roselli-Rehfuss, L. et al. Identification of a receptor for γ melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl Acad. Sci. USA 90, 8856-8860 (1993).
14. Johnson, P.R. & Hirsch, J. Cellularity of adipose depots in six strains of genetically obese mice. J. Lipid Res. 13, 2-11 (1972).
15. vy/a mice. Biochem. Biophys. Acta 441, 213-220 (1976).
16. Yen, T.T., Steinmetz, J. & Wolff, G.L. Lipolysis in genetically obese and diabetes-prone mice. Horm. Metab. Res. 2, 200-203 (1970).
17. Jones, B.H. et al. Upregulation of adipocyte metabolism by agouti protein: possible paracrine actions in yellow mouse obesity. Am. J. Physiol. 270, E192-E196 (1996).
18. 2+-dependent mechanism. FASEB 12, 1391-1396 (1998).
19. Fekete, C. et al. α-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J. Neurosci. 20, 1550-1558 (2000).
20. Kim, M.S. et al. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J. Clin. Invest. 105, 1005-1011 (2000).
21. 1 hybrid mice to the same diets: glucose tolerance, weight gain, and adipocyte cellularity. Int. J. Obes. 12, 305-320 (1988).
22. Shimizu, H., Shargill, N.S., Bray, G.A., Yen, T.T. & Geselichen, P.D. Effects of MSH on food intake, body weight and coat color of the yellow obese mouse. Life Sci. 45, 543-552 (1989).
23. Hruby, V.J. et al. Cyclic lactam α-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7, Lys10] α-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 38, 3454-3461 (1995).
24. Bagnol, D. et al. Anatomy of an endogenous antagonist: relationship between agouti-related protein and proopiomelanocortin in brain. J. Neurosci. 19, RC26 (1-7) (1999).
25. Gantz, I. et al. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268, 8246-8250 (1993).
26. Chhajlani, V. Distribution of cDNA for melanocortin receptor subtypes in human tissues, Biochem. Mol. Biol. Int. 38, 73-80 (1996).
27. Lembertas, A.V. et al. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J. Clin. Invest 100, 1240-1247 (1997).
28. Guan, X.-M., Yu, H. & Van der Ploeg, L.H.T. Evidence of altered hypothalamic proopiomelanocortin/neuropeptide Y mRNA expression in tubby mice. Mol. Brain Res. 59, 273-279 (1998).
29. Kelly, T.L., Berger, N. & Richardson, T.L. DXA body composition: theory and practice. Appl. Radiat. Isot. 49, 511-513 (1998).
30. Ellis, K.J. Human body composition: in vivo methods. Physiol. Rev. 80, 649-680 (2000).